The U.S. biotechnology industry is awaiting this fall's deadline for Europe to speed up its approval of new biotech food and crops -- a process Washington has long complained is woefully slow -- in the hope of increased access to a major market. After a World Trade Organization ruling last year found "undue delays" in Europe's approval of biotech products, the EC has until November 21 to bring its system up to speed.